Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 535

1.

Impact of atypical antipsychotics on quality of life in patients with schizophrenia.

Awad AG, Voruganti LN.

CNS Drugs. 2004;18(13):877-93. Review.

PMID:
15521791
2.
3.

Measuring quality of life in patients with schizophrenia.

Awad AG, Voruganti LN, Heslegrave RJ.

Pharmacoeconomics. 1997 Jan;11(1):32-47. Review.

PMID:
10172917
4.

Practical issues with amisulpride in the management of patients with schizophrenia.

Pani L, Villagrán JM, Kontaxakis VP, Alptekin K.

Clin Drug Investig. 2008;28(8):465-77. Review.

PMID:
18598092
5.

Children with schizophrenia: clinical picture and pharmacological treatment.

Masi G, Mucci M, Pari C.

CNS Drugs. 2006;20(10):841-66. Review.

PMID:
16999454
6.

[Leponex, 10 years after -- a clinical review].

Llorca PM, Pere JJ.

Encephale. 2004 Sep-Oct;30(5):474-91. Review. French.

PMID:
15627052
7.
8.

The new and evolving pharmacotherapy of schizophrenia.

Emsley R, Oosthuizen P.

Psychiatr Clin North Am. 2003 Mar;26(1):141-63. Review.

PMID:
12683264
9.

[New chemotherapy approaches to psychoses].

Olié JP, Baylé FJ.

Encephale. 1997 Apr;23 Spec No 2:2-9. Review. French.

PMID:
9273302
10.

The SOHO (Schizophrenia Outpatient Health Outcome) study: implications for the treatment of schizophrenia.

Haro JM, Salvador-Carulla L.

CNS Drugs. 2006;20(4):293-301. Review.

PMID:
16599647
11.

Amisulpride: a review of its use in the management of schizophrenia.

McKeage K, Plosker GL.

CNS Drugs. 2004;18(13):933-56. Review.

PMID:
15521794
12.

Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.

Maher AR, Theodore G.

J Manag Care Pharm. 2012 Jun;18(5 Suppl B):S1-20. Review.

PMID:
22784311
13.

Quality of life in the long-term treatment and the role of second-generation antipsychotics.

Mohr P.

Neuro Endocrinol Lett. 2007 Feb;28 Suppl 1:117-33. Review.

PMID:
17262004
14.

Antipsychotic medication, functional outcome and quality of life in schizophrenia: focus on amisulpride.

Nuss P, Tessier C.

Curr Med Res Opin. 2010 Apr;26(4):787-801. doi: 10.1185/03007990903576953. Review.

PMID:
20121655
15.

Adverse effects of atypical antipsychotics : differential risk and clinical implications.

Haddad PM, Sharma SG.

CNS Drugs. 2007;21(11):911-36. Review.

PMID:
17927296
16.

The new atypical antipsychotics: a review of pharmacoeconomic studies.

Revicki DA.

Expert Opin Pharmacother. 2000 Jan;1(2):249-60. Review.

PMID:
11249546
17.
18.

Adverse effects of antipsychotic agents. Do newer agents offer advantages?

Owens DG.

Drugs. 1996 Jun;51(6):895-930. Review.

PMID:
8736614
19.

Risperidone. A pharmacoeconomic review of its use in schizophrenia.

Foster RH, Goa KL.

Pharmacoeconomics. 1998 Jul;14(1):97-133. Review.

PMID:
10182198
20.

Use and safety of antipsychotic drugs during pregnancy.

Einarson A, Boskovic R.

J Psychiatr Pract. 2009 May;15(3):183-92. doi: 10.1097/01.pra.0000351878.45260.94. Review.

PMID:
19461391

Supplemental Content

Support Center